Novartis's aircraft lands in New Jersey after a week of US manufacturing announcements

Novartis's Dassault Falcon 7X, registration HB-JFQ, was tracked flying from John Glenn Columbus International Airport to Morristown Municipal Airport on July 1, 2026, a short 1-hour 9-minute hop across Ohio and Pennsylvania. The aircraft had arrived in Columbus the previous day from Morristown, suggesting a brief midwest stopover before returning to the New Jersey area.

If Novartis executives were aboard, the flight lands the same week the company is finalizing its seventh new US facility — an API manufacturing plant in Morrisville, North Carolina, per a Novartis press release on April 30. This follows a Q1 earnings miss reported by Reuters on April 28, where sales of blockbuster drug Entresto dropped 42% due to generic competition, and a $23 billion US investment plan tied to tariff relief under the Trump administration's drug pricing policy. Morristown is a short drive from Novartis's US subsidiary headquarters in East Hanover, New Jersey, making it a logical base for meetings with US operations.

The aircraft's recent flight history shows a transatlantic pattern: it flew from Basel to San Francisco on June 28, then to New York on June 30, before the Columbus detour. This suggests a multi-stop US tour, possibly to inspect new facilities or meet with regulators and investors amid the company's push to manufacture all key US medicines domestically.